Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
IPO Year: 2013
Exchange: NYSE
Website: veeva.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/27/2024 | $256.00 → $273.00 | Buy | Citigroup |
7/9/2024 | $240.00 | Buy | BTIG Research |
10/25/2023 | $211.00 → $229.00 | Equal Weight → Overweight | Wells Fargo |
10/13/2023 | $265.00 | Buy | Jefferies |
6/28/2023 | $181.00 | Equal-Weight → Underweight | Morgan Stanley |
6/1/2023 | $226.00 | Neutral → Buy | Guggenheim |
3/17/2023 | $205.00 → $195.00 | Buy → Hold | Truist |
2/23/2023 | Buy → Neutral | Guggenheim | |
1/4/2023 | $205.00 | Equal Weight → Overweight | Barclays |
12/6/2022 | $184.00 | Market Perform | Cowen |
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
4 - VEEVA SYSTEMS INC (0001393052) (Issuer)
New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect PLEASANTON, Calif., Sept. 5, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced, in a major step forward for clinical trial execution, the newest release of Veeva Site Connect, adding powerful new capabilities and a streamlined site-centric experience to simplify and standardize sponsor-site collaboration. With Veeva Site Connect, sponsors reduce the time and effort of site start-up, study conduct, and closeout for higher-quality trials at a signifi
PLEASANTON, Calif., Aug. 30, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced participation in the following investor conference: Citi 2024 Global TMT Conference, New York, NY. Paul Shawah, EVP Strategy, is presenting on Wednesday, September 4, 2024, at 3:00 p.m. Eastern Time.The above presentation will be webcast. Link to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com. About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutica
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif., Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024. "It was another quarter of great execution, with major product advances in clinical and CRM that position us well for the industry cloud opportunity we see ahead," said CEO Peter Gassner. "Thanks to the team's focus on product excell
Vault CRM Service Center now available for life sciences inside sales, contact center, and hybrid reps Vault CRM Suite to unify sales, marketing, medical, and service for true customer-centricity PLEASANTON, Calif., Aug. 27, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced Veeva Vault CRM Service Center for inside sales, contact center, and hybrid reps. Supporting inbound and outbound engagement across channels, Vault CRM Service Center includes case management, video calls, telephony integration, and industry-specific capabilities including consent, sampling, call reporting, and a foundation of compliant content. It also features Microsoft 365 integration which drives producti
Life sciences organizations now manage all quality control data and processes in one solution for greater efficiency and speed PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced increasing momentum for Veeva Vault LIMS, a modern cloud solution that simplifies end-to-end quality control (QC) business processes. Vault LIMS is unified with Veeva Vault Quality, enabling customers to share data and content across quality applications for more informed batch release decisions. "Adopting Veeva Vault LIMS to replace a paper-based documentation
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that industry leaders from AbbVie, Astellas, Eikon Therapeutics, Merck & Co., Moderna, and Roche will keynote at the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10. Professionals across life sciences will come together to discuss how connected systems across clinical, regulatory, safety, and quality can move the industry forward for the benefit of patients. Veeva R&D
PLEASANTON, Calif., Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2025 Second Quarter Results Conference Call Date: Wednesday, August 28, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: htt
New Veeva Pulse findings show congresses and early-career experts have the strongest influence on patient outcomes PLEASANTON, Calif., July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing in pre-launch scientific activities and prioritizing congresses gain 40% faster treatment adoption than those that invested less. Early-career experts are also more open to digital engagement and four times more likely to start patients on a new treatment.
CRO will use Veeva Vault EDC to deliver a better experience to patients, research sites, and sponsors PLEASANTON, Calif., June 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Vita Global Sciences is partnering with Veeva to modernize its clinical data management processes and improve collaboration with key trial stakeholders. With Veeva Vault EDC, the CRO is establishing a foundation for study efficiency and faster study builds. "Veeva Vault EDC allows us to simplify our processes while ensuring a seamless experience for patients, research sites, and s
Modern EDC streamlines key processes to accelerate study builds and make mid-study amendments with no downtime PLEASANTON, Calif., June 6, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced that Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed") has selected Veeva Vault EDC as its technology foundation for modern electronic data capture (EDC). With Vault EDC, Tigermed can simplify complex data management for faster study builds and mid-study amendments with zero downtime. The improvements can significantly advance Tigermed's clinical data management for the benefit of its customers and the industry.
10-Q - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
8-K - VEEVA SYSTEMS INC (0001393052) (Filer)
ARS - VEEVA SYSTEMS INC (0001393052) (Filer)
DEF 14A - VEEVA SYSTEMS INC (0001393052) (Filer)
DEFA14A - VEEVA SYSTEMS INC (0001393052) (Filer)
PLEASANTON, Calif., Jan. 25, 2022 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) today announced the appointments of Tim Cabral, Priscilla Hung, Tina Hunt, and Marshall Mohr to its board of directors. Veeva also announced Ron Codd will retire from the board at the end of his current term in June 2022. "We are pleased to welcome Tim, Priscilla, Tina, and Marshall, who bring a range of experience in life sciences and enterprise software to the Veeva board," said Veeva CEO Peter Gassner. "I would also like to thank Ron Codd for a decade of partnership and contributions to Veeva." Th
BARCELONA, Spain--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its certificate of inc
PLEASANTON, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions. The updated release reads: VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT CORPORATION Aligns legal charter with company’s long-term view and commitment to all stakeholders, including customers, employees, and shareholders Proposal passes by landslide as Veeva garners widespread support for leading in stakeholder capitalism Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majorit
PLEASANTON, Calif.--(BUSINESS WIRE)--Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote today, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the vast majority of Veeva’s largest shareholders. With today’s shareholder approval, Veeva will become a public benefit corporation on Feb. 1, 2021, making it the first publicly traded company and largest-ever to convert to a PBC. As a PBC, Veeva will remain a for-profit corporation but will be legally responsible to balance the interests of multiple stakeholders, including customers, employees, partners, and shareholders. It will also broaden its ce
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
SC 13G/A - VEEVA SYSTEMS INC (0001393052) (Subject)
Total Revenues of $676.2M, up 15% Year Over Year;Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif., Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024. "It was another quarter of great execution, with major product advances in clinical and CRM that position us well for the industry cloud opportunity we see ahead," said CEO Peter Gassner. "Thanks to the team's focus on product excell
PLEASANTON, Calif., Aug. 7, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2024, after market close on August 28, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2025 Second Quarter Results Conference Call Date: Wednesday, August 28, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: htt
Total Revenues of $650.3M, up 24% Year Over Year;Subscription Services Revenues of $534.0M, up 29% Year Over Year PLEASANTON, Calif., May 30, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its first quarter ended April 30, 2024. "Thanks to our customers and the Veeva team we had an excellent start to the year," said CEO Peter Gassner. "We made major progress in Development Cloud, Commercial Cloud, and Data Cloud." Fiscal 2025 First Quarter Results: Revenues(1
PLEASANTON, Calif., May 8, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter, which ended April 30, 2024, after market close on May 30, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2025 First Quarter Results Conference Call Date: Thursday, May 30, 2024 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference Call Registration: https://registr
Fiscal Year 2024 Total Revenues of $2,363.7M, up 10% Year Over Year;Q4 Total Revenues of $630.6M, up 12% Year Over Year Fiscal Year 2024 Subscription Services Revenues of $1,901.6M, up 10% Year Over Year;Q4 Subscription Services Revenues of $521.5M, up 13% Year Over Year PLEASANTON, Calif., Feb. 29, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fourth quarter and fiscal year ended January 31, 2024. "The fourth quarter was a strong finish to an important
PLEASANTON, Calif. , Feb. 6, 2024 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year, which ended January 31, 2024, after market close on February 29, 2024. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2024 Fourth Quarter and Full Year Results Conference Call Date: Thursday, February 29, 2024 Time: 2:00 p.m. PT (5:00 p.m
Total Revenues of $616.5M, up 12% Year Over Year; Subscription Services Revenues of $494.9M, up 12% Year Over Year PLEASANTON, Calif., Dec. 6, 2023 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2023. "It was another strong quarter as we advance the industry toward more efficient and effective ways of working, from drug development through commercialization," said CEO Peter Gassner. "We announced a number of new innovations, exp
PLEASANTON, Calif., Nov. 15, 2023 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its third quarter, which ended October 31, 2023, after market close on December 6, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2024 Third Quarter Results Conference Call Date: Wednesday, December 6, 2023 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference
Total Revenues of $590.2M, up 10% Year Over Year;Subscription Services Revenues of $470.6M, up 10% Year Over Year PLEASANTON, Calif., Aug. 30, 2023 /PRNewswire/ -- Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2023. "We had a great quarter with progress across the board that was particularly significant in CRM and clinical," said CEO Peter Gassner. "Thanks to our customers for your partnership and to the Veeva team for your continued focus on cu
PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) will announce financial results for its second quarter, which ended July 31, 2023, after market close on August 30, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results. Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event. Event: Veeva's Fiscal 2024 Second Quarter Results Conference Call Date: Wednesday, August 30, 2023 Time: 2:00 p.m. PT (5:00 p.m. ET) Conference C
Citigroup reiterated coverage of Veeva Systems with a rating of Buy and set a new price target of $273.00 from $256.00 previously
BTIG Research initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $240.00
Wells Fargo upgraded Veeva Systems from Equal Weight to Overweight and set a new price target of $229.00 from $211.00 previously
Jefferies initiated coverage of Veeva Systems with a rating of Buy and set a new price target of $265.00
Morgan Stanley downgraded Veeva Systems from Equal-Weight to Underweight and set a new price target of $181.00
Guggenheim upgraded Veeva Systems from Neutral to Buy and set a new price target of $226.00
Truist downgraded Veeva Systems from Buy to Hold and set a new price target of $195.00 from $205.00 previously
Guggenheim downgraded Veeva Systems from Buy to Neutral
Barclays upgraded Veeva Systems from Equal Weight to Overweight and set a new price target of $205.00
Cowen initiated coverage of Veeva Systems with a rating of Market Perform and set a new price target of $184.00
Guggenheim analyst Jack Wallace maintains Veeva Systems (NYSE:VEEV) with a Buy and raises the price target from $211 to $233.
Needham analyst Ryan MacDonald reiterates Veeva Systems (NYSE:VEEV) with a Buy and maintains $260 price target.
Piper Sandler analyst Brent Bracelin maintains Veeva Systems (NYSE:VEEV) with a Overweight and lowers the price target from $235 to $225.
During the last three months, 15 analysts shared their evaluations of Veeva Systems (NYSE:VEEV), revealing diverse outlooks from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 5 5 1 0 Last 30D 1 0 0 0 0 1M Ago 0 1 1 0 0 2M Ago 3 4 4 1 0 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $222.67, along with a high estimate of $260.00 and a low estimate of $173.00. A 7.44% drop is evi
BTIG analyst David Larsen initiates coverage on Veeva Systems (NYSE:VEEV) with a Buy rating and announces Price Target of $240.
Veeva Systems's (NYSE:VEEV) short percent of float has fallen 4.05% since its last report. The company recently reported that it has 2.09 million shares sold short, which is 1.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.45 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 11.53% on an annualized basis producing an average annual return of 22.36%. Currently, Veeva Systems has a market capitalization of $29.56 billion. Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,352.23 today based on a price of $182.85 for VEEV at the time of writing. Veeva Systems's Performance Over Last 10 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated cont
RBC Capital analyst Rishi Jaluria reiterates Veeva Systems (NYSE:VEEV) with a Outperform and maintains $250 price target.
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. Below are some instances of options activity happening in the Health Care sector: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume CYH CALL SWEEP BEARISH 07/19/24 $3.00 $57.8K 3.6K 2.1K UNH PUT SWEEP BEARISH 01/16/26